Brief: XSpray Pharma Q1 Pre-Tax Loss At SEK 8.5 Million
16/05/2019 07:54
May 16 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* Q1 EARNINGS BEFORE TAX AMOUNTED TO SEK -8,503 THOUSAND
Source text for Eikon: ID:nWkr32m5T5
Further company coverage: XSPRAY.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003